Maximo Navarro , APRN
Nurse Practitioner • Miami, FL
3801 Biscayne Blvd, Ste 300
Miami, FL 331379800
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on August 9, 2005; this date does not establish years in practice.
-
Published CMS data list 370 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Carvedilol — 49 prescription fills, including refills.
- Atorvastatin Calcium — 43 prescription fills, including refills.
- Amlodipine Besylate — 42 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 13 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 60% of clinicians listed under Nurse Practitioner in Miami, FL (2024, 283 clinicians with data). Median for this group: 163. Middle half: 45 to 624.
Close to the middle for Part D prescriptions among clinicians listed under Nurse Practitioner in Florida (2024, 3,506 clinicians with data). Median for this group: 306. Middle half: 76 to 1,100.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 33 in 2020 to 370 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
3801 Biscayne Blvd
Ste 300
Miami, FL 331379800
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Nurse Practitioner: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
914 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$67,376 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $739.15 across 18 records.
By nature of payment
- Food and Beverage: $739.15 across 18 records.
Reporting-company totals (3 largest of 11)
- Boston Scientific Corporation: $170.95 across 1 record.
- Medtronic, Inc.: $163.16 across 3 records.
- Cagent Vascular INC: $149.03 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2005
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Maximo Navarro has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Maximo Navarro as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Miami and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 60% of clinicians listed under Nurse Practitioner in Miami, FL (2024, 283 clinicians with data). Median for this group: 163. Middle half: 45 to 624.
Close to the middle for clinicians listed under Nurse Practitioner in Florida (2024, 3,506 clinicians with data). Median for this group: 306. Middle half: 76 to 1,100.
Part D drug cost
A higher Part D drug cost than 60% of clinicians listed under Nurse Practitioner in Miami, FL (2024, 283 clinicians with data). Median for this group: $15,606. Middle half: $990 to $182,231.
A higher Part D drug cost than 65% of clinicians listed under Nurse Practitioner in Florida (2024, 3,506 clinicians with data). Median for this group: $18,227. Middle half: $1,370 to $130,581.
955 active clinicians are listed under Nurse Practitioner with a practice address in Miami, FL (8,853 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Miami
10.9% of these 955 clinicians have the CMS telehealth indicator.
38.5% of these 955 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 1021% from 33 in 2020 to 370 in 2024.
- 2020: 33
- 2021: 126
- 2022: 251
- 2023: 468
- 2024: 370
-
30-day fills
30-day fills increased 1087% from 77 in 2020 to 914 in 2024.
- 2020: 77
- 2021: 323
- 2022: 594
- 2023: 1,122
- 2024: 914
-
Part D drug cost
Part D drug cost increased 436% from $12,578 in 2020 to $67,376 in 2024.
- 2020: $12,578
- 2021: $20,204
- 2022: $26,844
- 2023: $147,811
- 2024: $67,376
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $911.17 in 2021 to $739.15 in 2025.
- 2021: $911.17
- 2022: $2,037.40
- 2023: $814.56
- 2024: $1,308.02
- 2025: $739.15
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 18 records totaling $739.15.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
WATCHMAN FLX | General | $170.95 |
| Cagent Vascular INC |
Food and Beverage
Cash or cash equivalent
|
Serrantor | General | $149.03 |
| Medtronic, Inc. |
Food and Beverage
In-kind items and services
|
MYCARELINK | General | $91.57 |
| Medtronic, Inc. |
Food and Beverage
In-kind items and services
|
MYCARELINK | General | $53.30 |
| BridgeBio Pharma, Inc. |
Food and Beverage
In-kind items and services
|
Attruby | General | $32.88 |
| BridgeBio Pharma, Inc. |
Food and Beverage
In-kind items and services
|
Attruby | General | $30.88 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
VYNDAQEL | General | $27.35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $22.77 |
| Medtronic, Inc. |
Food and Beverage
In-kind items and services
|
MICRA | General | $18.29 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
WAINUA | General | $18.04 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $17.89 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
WAINUA | General | $17.14 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EVKEEZA | General | $16.87 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
WAINUA | General | $15.29 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
WAINUA | General | $15.07 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $14.66 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $13.67 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
VERQUVO | General | $13.50 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Carvedilol | Carvedilol | 49 | 3,710 | $361.51 | 18 |
| Atorvastatin Calcium | Atorvastatin Calcium | 43 | 3,870 | $492.14 | 21 |
| Amlodipine Besylate | Amlodipine Besylate | 42 | 3,720 | $156.40 | 24 |
| Brilinta | Ticagrelor | 38 | 2,276 | $33,468.80 | 15 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 37 | 2,790 | $529.58 | — |
| Clopidogrel | Clopidogrel Bisulfate | 33 | 2,316 | $435.54 | 13 |
| Furosemide | Furosemide | 26 | 1,680 | $64.71 | — |
| Losartan Potassium | Losartan Potassium | 24 | 2,040 | $176.99 | — |
| Metoprolol Succinate | Metoprolol Succinate | 17 | 1,530 | $182.73 | — |
| Nifedipine Er | Nifedipine | 17 | 912 | $479.29 | — |
| Eliquis | Apixaban | 16 | 875 | $17,047.82 | — |
| Hydrochlorothiazide | Hydrochlorothiazide | 15 | 940 | $57.88 | — |
| Xarelto | Rivaroxaban | 13 | 720 | $13,922.64 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2025-05-02NUCC Taxonomy Code: 363L00000X
(1) A registered nurse provider with a graduate degree in nursing prepared for advanced practice involving independent and interdependent decision making and direct accountability for clinical judgment across the health care continuum or in a certified specialty. (2) A registered nurse who has completed additional training beyond basic nursing education and who provides primary health care services in accordance with state nurse practice laws or statutes. Tasks performed by nurse practitioners vary with practice requirements mandated by geographic, political, economic, and social factors. Nurse practitioner specialists include, but are not limited to, family nurse practitioners, gerontological nurse practitioners, pediatric nurse practitioners, obstetric-gynecologic nurse practitioners, and school nurse practitioners.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NURSE PRACTITIONER
I20040325000392
FL
1557253721
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine - Interventional Cardiology
Internal Medicine - Cardiovascular Disease
Doctor of Medicine (M.D.)
Family Medicine
Doctor of Medicine (M.D.)
Internal Medicine - Cardiovascular Disease
Doctor of Medicine (M.D.)
Internal Medicine - Interventional Cardiology
Doctor of Medicine (M.D.)
Internal Medicine - Interventional Cardiology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Recorded as MAXIMO NAVARRO, APRN
NPI status registered as active in NPPES database
Registered at 3801 BISCAYNE BLVD, STE 300, MIAMI, FL 331379800 (Tel: 3055710620)
Registered at 3801 BISCAYNE BLVD, STE 300, MIAMI, FL 331379800 (Tel: 3055710620)
Recorded as MAXIMO NAVARRO, ARNP
Nurse Practitioner (license number reported to NPPES: FL ARNP3103392)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Nurse Practitioners in Miami
- Carole Lahana, ARNP
- Yiksiam Marquez Fernandez
- Adisbel Espinosa Ramirez, ARNP
- Sarita Khanal, MSN, ARNP
- Hilda Dominguez, ARNP
- Allison Wick
Mailing Address
3801 Biscayne Blvd, Ste 300
Miami, FL 331379800
Phone: 3055710620